查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1585581

生物製藥物流市場：依產品、運輸、運輸方式 - 全球預測 2025-2030

Bio-Pharmaceutical Logistics Market by Product (Branded Drugs, Generic Drugs), Transport (Cold-Chain Transport, Non Cold-Chain Transport), Mode of Transportation - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物製藥物流市場價值為152.1億美元，預計到2024年將達到169.2億美元，複合年成長率為11.29%，到2030年將達到321.8億美元。

生物醫學物流領域包括藥品和生技藥品的運輸、儲存和配送，需要嚴格的溫度控制、特殊處理和及時交付。從製造商到醫院、藥房和診所等最終用戶，需要保持溫度敏感疫苗、生技藥品和複雜藥物的完整性和有效性，這凸顯了該行業的重要性。該領域的關鍵應用包括低溫運輸物流、供應鏈管理和貨運，確保產品安全到達並符合監管標準。對於廣泛的最終用途，包括製藥公司、醫療保健提供者和研究機構，高效的物流使藥品更容易取得和取得。

主要市場統計
基準年[2023] 152.1億美元
預測年份 [2024] 169.2億美元
預測年份 [2030] 321.8億美元
複合年成長率（%） 11.29%

市場成長受到藥物研發活動活性化、世界慢性病盛行率增加以及個人化醫療出現的顯著影響。生技藥品和生物相似藥的激增，以及先進包裝技術和即時資料監控解決方案的進步，為向該市場提供創新服務提供了重大機會。為了利用這些機會，企業應專注於實施下一代物流技術，例如用於增強追蹤的物聯網和人工智慧以及用於透明供應鏈的區塊鏈。然而，挑戰包括高昂的營運成本、嚴格的監管要求以及處理生技藥品的複雜性，這些可能會對市場進入和擴張造成障礙。

在創新方面，企業可以考慮投資更永續、更環保的物流解決方案，以解決環境問題。這包括開發更有效率的冷藏解決方案以及在供應鏈中利用可再生能源。此外，與高科技公司合作開發簡化物流業務的整合數位平台可以提供競爭優勢。該市場的特點是競爭激烈、技術進步迅速，需要敏捷性和策略夥伴關係才能保持領先。產業參與者有潛力提高供應鏈透明度和效率、重新定義競爭動態並最佳化市場覆蓋範圍。

市場動態：揭示快速發展的生物製藥物流市場的關鍵市場洞察

供需的動態交互作用正在改變生物製藥物流市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 生物製藥產業對細胞療法、疫苗和血液製品的需求不斷成長
    • 高銷售量帶動全球生物製藥進出口需求
    • 醫療保健領域的及時支援越來越重要
  • 市場限制因素
    • 運輸成本高
  • 市場機會
    • 物流持續創新與雲端運算融合
    • 外包運輸服務的需求不斷成長
  • 市場挑戰
    • 產品效率低和定價政策波動

波特五力：駕馭生物製藥物流市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解生物製藥物流市場的外部影響

外部宏觀環境因素對生物醫學物流市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物製藥物流市場的競爭格局

對生物製藥物流市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生物物流市場供應商的績效評估

FPNV 定位矩陣是評估生物製藥物流市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了生物製藥物流市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，生物製藥物流市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生物製藥產業對細胞療法、疫苗和血液製品的需求不斷成長
      • 銷售量高 全球生物醫藥進出口需求增加
      • 醫療保健領域的及時支援變得越來越重要
    • 抑制因素
      • 運輸成本高
    • 機會
      • 雲端運算物流與整合持續創新
      • 外包運輸服務的需求不斷成長
    • 任務
      • 產品效率低和定價政策波動
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物製藥物流市場：依產品

  • 品牌藥品
  • 學名藥

第7章 生物醫學物流市場運輸

  • 低溫運輸運輸
  • 非低溫運輸運輸

第8章生物醫學物流市場：依交通途徑

  • 空運
  • 鐵路運輸
  • 陸運
  • 海運

第9章美洲生物醫藥物流市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太生物醫學物流市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲生物醫學物流市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AmerisourceBergen Corporation
  • Bio Pharma Logistics
  • BL Turkey
  • CH Robinson Worldwide, Inc.
  • CAVALIER LOGISITICS
  • Ceva Logistics LLC
  • DB Schenker AG
  • Deutsche Post DHL Group
  • Fedex Corporation
  • Kerry Logistics Network Limited
  • Kuhne+Nagel Management AG
  • Nippon Express Co., Ltd.
  • Sentry BioPharma Services, Inc.
  • United Parcel Service of America, Inc.
Product Code: MRR-437D459587C9

The Bio-Pharmaceutical Logistics Market was valued at USD 15.21 billion in 2023, expected to reach USD 16.92 billion in 2024, and is projected to grow at a CAGR of 11.29%, to USD 32.18 billion by 2030.

The bio-pharmaceutical logistics sector encompasses the transportation, storage, and distribution of drugs and biologics that require stringent temperature controls, specialized handling, and timely deliveries. This industry's criticality is underscored by the necessity to maintain the integrity and efficacy of temperature-sensitive vaccines, biologics, and complex medicines from manufacturers to end-users, including hospitals, pharmacies, and clinics. Key applications within this domain include cold chain logistics, supply chain management, and freight forwarding, ensuring that products arrive safely and in compliance with regulatory standards. The end-use scope is expansive, spanning pharmaceutical companies, healthcare providers, and research organizations that rely on efficient logistics to facilitate the accessibility and availability of medications.

KEY MARKET STATISTICS
Base Year [2023] USD 15.21 billion
Estimated Year [2024] USD 16.92 billion
Forecast Year [2030] USD 32.18 billion
CAGR (%) 11.29%

Market growth is significantly influenced by increased pharmaceutical R&D activities, a rise in the global incidences of chronic diseases, and the advent of personalized medicine. The proliferation of biologics and biosimilars, alongside advancements in packaging technologies and real-time data monitoring solutions, present substantial opportunities for innovative service offerings in this market. To leverage these opportunities, companies should focus on adopting next-generation logistics technologies, such as IoT and AI for enhanced tracking, and blockchains for transparent supply chains. However, challenges include high operational costs, stringent regulatory requirements, and the complexity of handling biologics, which can pose barriers to market entry and expansion.

In terms of innovation, companies can explore investing in more sustainable and eco-friendly logistics solutions to address environmental concerns. This includes developing more efficient cold storage solutions and utilizing renewable energy sources within the supply chain. Additionally, collaborations with tech firms for integrated digital platforms that streamline logistics operations could offer a competitive edge. The market is characterized by robust competition and rapid technological advancements, necessitating agility and strategic partnerships to remain ahead. Therein lies an opportunity for industry players to enhance supply chain transparency and efficiency, potentially redefining competitive dynamics and optimizing market reach in the bio-pharmaceutical logistics sphere.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bio-Pharmaceutical Logistics Market

The Bio-Pharmaceutical Logistics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion in the demand for cellular therapies, vaccines and blood products in the bio-pharmaceutical industry
    • High sales drive the demand of global export import of Bio-pharmaceutical product
    • Rising importance of fast-track assistance in the healthcare sector
  • Market Restraints
    • High cost of transportation
  • Market Opportunities
    • Ongoing innovations in the logistics and integration of cloud computing
    • Growing demand for outsourcing transportation services
  • Market Challenges
    • Inefficient products and fluctuation in the pricing policies

Porter's Five Forces: A Strategic Tool for Navigating the Bio-Pharmaceutical Logistics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bio-Pharmaceutical Logistics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bio-Pharmaceutical Logistics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bio-Pharmaceutical Logistics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bio-Pharmaceutical Logistics Market

A detailed market share analysis in the Bio-Pharmaceutical Logistics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bio-Pharmaceutical Logistics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bio-Pharmaceutical Logistics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bio-Pharmaceutical Logistics Market

A strategic analysis of the Bio-Pharmaceutical Logistics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bio-Pharmaceutical Logistics Market, highlighting leading vendors and their innovative profiles. These include AmerisourceBergen Corporation, Bio Pharma Logistics, BL Turkey, C.H. Robinson Worldwide, Inc., CAVALIER LOGISITICS, Ceva Logistics LLC, DB Schenker AG, Deutsche Post DHL Group, Fedex Corporation, Kerry Logistics Network Limited, Kuhne + Nagel Management AG, Nippon Express Co., Ltd., Sentry BioPharma Services, Inc., and United Parcel Service of America, Inc..

Market Segmentation & Coverage

This research report categorizes the Bio-Pharmaceutical Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Branded Drugs and Generic Drugs.
  • Based on Transport, market is studied across Cold-Chain Transport and Non Cold-Chain Transport.
  • Based on Mode of Transportation, market is studied across Air Shipping, Rail Shipping, Road Shipping, and Sea Shipping.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion in the demand for cellular therapies, vaccines and blood products in the bio-pharmaceutical industry
      • 5.1.1.2. High sales drive the demand of global export import of Bio-pharmaceutical product
      • 5.1.1.3. Rising importance of fast-track assistance in the healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of transportation
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations in the logistics and integration of cloud computing
      • 5.1.3.2. Growing demand for outsourcing transportation services
    • 5.1.4. Challenges
      • 5.1.4.1. Inefficient products and fluctuation in the pricing policies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bio-Pharmaceutical Logistics Market, by Product

  • 6.1. Introduction
  • 6.2. Branded Drugs
  • 6.3. Generic Drugs

7. Bio-Pharmaceutical Logistics Market, by Transport

  • 7.1. Introduction
  • 7.2. Cold-Chain Transport
  • 7.3. Non Cold-Chain Transport

8. Bio-Pharmaceutical Logistics Market, by Mode of Transportation

  • 8.1. Introduction
  • 8.2. Air Shipping
  • 8.3. Rail Shipping
  • 8.4. Road Shipping
  • 8.5. Sea Shipping

9. Americas Bio-Pharmaceutical Logistics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bio-Pharmaceutical Logistics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bio-Pharmaceutical Logistics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AmerisourceBergen Corporation
  • 2. Bio Pharma Logistics
  • 3. BL Turkey
  • 4. C.H. Robinson Worldwide, Inc.
  • 5. CAVALIER LOGISITICS
  • 6. Ceva Logistics LLC
  • 7. DB Schenker AG
  • 8. Deutsche Post DHL Group
  • 9. Fedex Corporation
  • 10. Kerry Logistics Network Limited
  • 11. Kuhne + Nagel Management AG
  • 12. Nippon Express Co., Ltd.
  • 13. Sentry BioPharma Services, Inc.
  • 14. United Parcel Service of America, Inc.

LIST OF FIGURES

  • FIGURE 1. BIO-PHARMACEUTICAL LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 2. BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIO-PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIO-PHARMACEUTICAL LOGISTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD-CHAIN TRANSPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON COLD-CHAIN TRANSPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR SHIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL SHIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD SHIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA SHIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 145. BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023